Financial results are a critical indicator of a company's performance and future prospects. When a company like AstraZeneca reports financial results that are below market expectations, it often leads to a decrease in stock price as investors adjust their expectations for future profitability and growth. The direct mention of worse-than-expected Q4 financial results is the primary reason for anticipating a negative short-term impact on AstraZeneca's stock price.